38 related articles for article (PubMed ID: 35769021)
1. Molecular Classification of Endometrial Endometrioid Carcinoma With Microcystic Elongated and Fragmented Pattern.
Ju B; Wu J; Sun L; Yang C; Yu H; Hao Q; Wang J; Zhang H
Int J Gynecol Pathol; 2024 May; 43(3):233-241. PubMed ID: 37733028
[TBL] [Abstract][Full Text] [Related]
2. The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas.
Joehlin-Price AS; McHugh KE; Stephens JA; Li Z; Backes FJ; Cohn DE; Cohen DW; Suarez AA
Am J Surg Pathol; 2017 Jan; 41(1):49-55. PubMed ID: 27740968
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide N-methyltransferase is related to MELF pattern invasion in endometrioid carcinoma.
Tahara S; Nojima S; Ohshima K; Hori Y; Sato K; Kurashige M; Matsui T; Okuzaki D; Morii E
Cancer Med; 2021 Dec; 10(23):8630-8640. PubMed ID: 34655178
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Tumor Immune Microenvironment in Endometrial Endometrioid Carcinoma, Grade 1 With DNA Mismatch Repair Protein Loss.
Hachisuga K; Kawakami M; Tomonobe H; Maenohara S; Kodama K; Yagi H; Yasunaga M; Onoyama I; Asanoma K; Yahata H; Oda Y; Kato K
Int J Gynecol Pathol; 2024 Jan; ():. PubMed ID: 38289146
[TBL] [Abstract][Full Text] [Related]
5. Clinical features related to lymphatic metastasis in grade 3 endometroid endometrial cancer: a retrospective cross-sectional study.
Wang B; Wang Q; Shi Y; Shao WY; Liao JB; Luo XZ; Chen XJ; Wang C
Chin Med J (Engl); 2021 Aug; 134(17):2102-2109. PubMed ID: 34435979
[TBL] [Abstract][Full Text] [Related]
6. Tumor Budding, p53, and DNA Mismatch Repair Markers in Sinonasal Intestinal-Type Adenocarcinoma: A Retrospective Study Supports the Adverse Prognostic Impact of Tumor Budding.
Puccio S; Azzarello G; Maffeis V; Laurino L; Mairani E; Conte F; Tessari N; Cazzador D; Zanoletti E; Politi D; Emanuelli E; Spinato G; Ausoni S
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791973
[TBL] [Abstract][Full Text] [Related]
7. Clinico-pathological evaluation of tumor budding in the oncological progression of colorectal cancer.
Giordano PG; Díaz Zelaya AG; Aguilera Molina YY; Taboada Mostajo NO; Ajete Ramos Y; Ortega García R; Peralta de Michelis E; Meneu Díaz JC
Med Clin (Barc); 2024 May; ():. PubMed ID: 38697893
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Significance of Tumor Budding in Breast Carcinoma.
Buch A; Jain K; Rathod H; Gore C
J Nepal Health Res Counc; 2024 Mar; 21(3):417-427. PubMed ID: 38615212
[TBL] [Abstract][Full Text] [Related]
9. The Relationship between Tumor Budding and Tumor Deposits in Patients with Stage III Colorectal Carcinoma.
Bilić Z; Zovak M; Glavčić G; Mužina D; Ibukić A; Košec A; Tomas D; Demirović A
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731112
[No Abstract] [Full Text] [Related]
10. Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patients.
Proppe L; Jagomast T; Beume S; Klapper L; Gitas G; Köster F; Perner S; Rody A; Ribbat-Idel J; Hanker LC
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7155-7164. PubMed ID: 36884115
[TBL] [Abstract][Full Text] [Related]
11. Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients.
Stögbauer F; Geß B; Brambs C; Lautizi M; Kacprowski T; Ourailidis I; Bronger H; Kiechle M; Noske A; Keller G; Jesinghaus M; Poremba C; Weichert W; Boxberg M
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568650
[TBL] [Abstract][Full Text] [Related]
12. Microcystic Elongated and Fragmented Pattern Invasion in Endometrial Cancer: Possible Prognostic Value to Precise and Individualized Therapeutic Strategies.
Iavazzo C; Fotiou A; Gkegkes ID; Vrachnis N
Medeni Med J; 2022 Dec; 37(4):352-353. PubMed ID: 36578170
[No Abstract] [Full Text] [Related]
13. Clinical-grade endometrial cancer detection system
Zhang X; Ba W; Zhao X; Wang C; Li Q; Zhang Y; Lu S; Wang L; Wang S; Song Z; Shen D
Front Oncol; 2022; 12():1040238. PubMed ID: 36408137
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic association and prognostic impact of microcystic, elongated and fragmented pattern invasion, combined with tumor budding in endometrioid endometrial cancer.
Qi X; Zhu L; Zhang B
J Obstet Gynaecol Res; 2022 Sep; 48(9):2431-2441. PubMed ID: 35769021
[TBL] [Abstract][Full Text] [Related]
15. Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion.
Santoro A; Angelico G; Inzani F; Spadola S; Arciuolo D; Valente M; Musarra T; Capelli G; Fanfani F; Gallotta V; Scambia G; Zannoni GF
Eur J Surg Oncol; 2021 Feb; 47(2):338-345. PubMed ID: 32788094
[TBL] [Abstract][Full Text] [Related]
16. Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancer.
Pelletier MP; Trinh VQ; Stephenson P; Mes-Masson AM; Samouelian V; Provencher DM; Rahimi K
Hum Pathol; 2017 Apr; 62():33-39. PubMed ID: 27864117
[TBL] [Abstract][Full Text] [Related]
17. Microcystic, Elongated, and Fragmented Pattern Invasion in Ovarian Endometrioid Carcinoma: Immunohistochemical Profile and Prognostic Implications.
Goldberg A; Hand L; DeCotiis D; Rosenblum N; Chan J
Int J Gynecol Pathol; 2018 Jan; 37(1):44-51. PubMed ID: 28319570
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance and prognostic value of myoinvasive patterns in endometrial endometrioid carcinoma.
Amălinei C; Aignătoaei AM; Balan RA; Giuşcă SE; Lozneanu L; Avădănei ER; Căruntu ID
Rom J Morphol Embryol; 2018; 59(1):13-22. PubMed ID: 29940607
[TBL] [Abstract][Full Text] [Related]
19. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
Lax SF; Tamussino KF; Lang PF
Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
